Cargando…
Induction of remission in autoimmune polyglandular syndrome type three (APS III): An old drug with new perspectives
The autoimmune polyglandular syndrome is a sequential chain of autoimmune events. Whenever diagnosed, the clinician's target should be induction of remission and if possible hindering its progression especially if associated with refractory vitiligo, resistant Grave's, or unexplained hyper...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230650/ https://www.ncbi.nlm.nih.gov/pubmed/30455916 http://dx.doi.org/10.1002/ccr3.1827 |